Molecules 2013, 18(5), 5251-5264; doi:10.3390/molecules18055251
Article

Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells

1email, 2email, 2email, 3email, 2email and 1,* email
Received: 18 March 2013; in revised form: 4 April 2013 / Accepted: 25 April 2013 / Published: 8 May 2013
(This article belongs to the Special Issue Selenium and Tellurium Chemistry)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: We report the development of a new microwave-based synthetic methodology mediated by Woollins’ reagent that allowed an efficient conversion of caffeine into 6-selenocaffeine. A preliminary evaluation on the modulation of antioxidant activity upon selenation of caffeine, using the DPPH assay, indicated a mild antioxidant activity for 6-selenocaffeine, contrasting with caffeine, that exhibited no antioxidant activity under the same experimental conditions. Interestingly, whereas 6-selenocaffeine has revealed to have a low cytotoxic potential in both MCF10A and MCF-7 breast cells (24 h, up to 100 µM, MTT assay), a differential effect was observed when used in combination with the anticancer agents doxorubicin and oxaliplatin in MCF-7 breast cancer cells. The co-treatment of doxorubicin (1 µM) and 6-selenocaffeine (100 µM) resulted in a slight decrease in cellular viability when compared to doxorubicin (1 µM) alone. Conversely, the seleno-caffeine derivative at the same concentration markedly increased the viability of oxaliplatin (100 µM)-treated cells (p < 0.01). Overall, this work highlights an emerging methodology to synthesize organoselenium compounds and points out the differential roles of 6-selenocaffeine in the modulation of the cytotoxicity of anticancer agents.
Keywords: organoselenium compounds; caffeine; modulator of the cytoxicity; oxaliplatin; doxorubicin; cancer therapy
PDF Full-text Download PDF Full-Text [655 KB, uploaded 18 June 2014 20:05 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Martins, I.L.; Miranda, J.P.; Oliveira, N.G.; Fernandes, A.S.; Gonçalves, S.; Antunes, A.M.M. Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells. Molecules 2013, 18, 5251-5264.

AMA Style

Martins IL, Miranda JP, Oliveira NG, Fernandes AS, Gonçalves S, Antunes AMM. Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells. Molecules. 2013; 18(5):5251-5264.

Chicago/Turabian Style

Martins, Inês L.; Miranda, Joana P.; Oliveira, Nuno G.; Fernandes, Ana S.; Gonçalves, Sandrina; Antunes, Alexandra M.M. 2013. "Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells." Molecules 18, no. 5: 5251-5264.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert